logo

Pliva

Sector: Residential • Location: Croatia

Source: International Finance Corporation (IFC)

Project
Completed

The project supports the growth and strategic development of Pliva, the leading pharmaceutical company in Central and Eastern Europe, and the only one that has produced a blockbuster drug through its original research. Pliva’s strategy for the future is to continue to build on its existing R&D expertise by focusing on both original research, and generic drug development. IFC investment will supp

Project Information FAQ

Project Information

4 Q
The project “Pliva” is an infrastructure initiative in the Residential sector, located in Croatia. Taiyo aggregates data on it from International Finance Corporation (IFC).

Want to explore the full details? View the full report

Participants

Sponsoring Agency

Obfuscated Data

Company

Obfuscated Data

Status

Original status

completed

Taiyo status

Obfuscated Data

Taiyo last update

00-00-0000

Available timestamps

00-00-0000

Available timestamp type

Obfuscated Data

Contact

Contact name

Obfuscated Data

Phone

0000000000

Email

ObfuscatedData@email.com

Address

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description

Description

The project supports the growth and strategic development of Pliva, the leading pharmaceutical company in Central and Eastern Europe, and the only one that has produced a blockbuster drug through its original research. Pliva’s strategy for the future is to continue to build on its existing R&D expertise by focusing on both original research, and generic drug development. IFC investment will support the construction and outfitting of a new 25,000 square meter Research and Development facility. Currently, the company''s R&D is conducted in three different locations and suffers from space limitations. Consolidation of R&D activities in one state of the art facility will increase efficiency and multi-disciplinary interaction. The layout and infrastructure of the new facility will ensure that all Pliva''s R&D activities will be performed in compliance with international quality requirements, or "Good Laboratory Practice" (GLP). About 55% of the facility will be dedicated to new product development and 45% of the facility will be dedicated to original research. The department for new product registration will also be located in the new facility. The investment will also result in a significant improvement in the working conditions of the scientists by increasing laboratory space per scientist to international standards. Pliva''s new R&D facility will employ about 500 people. The project is expected to have a broader positive impact on Croatian society through providing local scientists employment opportunities in their own country, helping to curb the high level of "brain drain" to employment opportunities outside of Croatia. Despite Pliva''s impressive financial performance, to date, the perceived country and macroeconomic risks have made it difficult for the Company to secure adequate long term financing at a reasonable cost. The World Bank Group''s priorities in Croatia have been to encourage private sector development and to support this process through rehabilitating the country''s industrial asset base and environmental standards. Finally, this project is compatible with IFC''s mission of attracting foreign investment and assisting through financing and advisory work with the restructuring and privatisation of formerly socially-owned enterprises.

Original sub-sector

Obfuscated

Original Currency

USD

Original budget

000000000000000

Procurement method

Obfuscated Data

Budget

000000000000000

Location

Region

Obfuscated

Country

Obfuscated

State

Obfuscated Data

County

Obfuscated

Location

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source

Source reliability

High

Data quality score

100%

Source

Obfuscated Data

URL

obfuscated_data,obfuscateddata.com

More Details

Project Type

Obfuscated Data

Article Published Date

Obfuscated Data